NIH-funded research NIH-funded research

Understanding how social interactions can help prevent heroin relapse

Official title: Neurobiological mechanisms underlying heroin relapse after social-induced abstinence and preference for social interaction vs. opioid drugs

Funded at U.s. National Institute on Drug Abuse · NIH-10496704 · Data updated 2026-11-12

This study looks at how spending time with friends might help people who have struggled with heroin addiction stay away from drugs, by comparing how the brain reacts to social interactions versus drug use, and it hopes to find new ways to support recovery through social connections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionU.s. National Institute on Drug Abuse
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2025
Funding year2022
NIH project number1FI2GM142476-01A1
Project IDNIH-10496704 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with heroin addiction who may benefit from alternative reward systems in their recovery process.

Less likely to help

Patients who are not currently experiencing opioid addiction or those who do not have access to social support may not benefit from this research.

What this research studies

This research investigates the neurobiological mechanisms that influence heroin relapse after a period of social-induced abstinence. By using a rat model, the study examines how social interactions can serve as a rewarding alternative to opioid drugs, potentially reducing the likelihood of relapse. The researchers aim to understand the brain's response to social rewards compared to drug rewards, providing insights into addiction recovery. The findings could help develop new treatment strategies that emphasize social engagement as a means to combat opioid addiction.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatment approaches that utilize social interactions to help individuals overcome heroin addiction.

How similar studies have gone: Previous studies have shown success in using alternative rewards to reduce drug-seeking behavior, but this specific approach focusing on social interactions is relatively novel.

Where this research is happening

  • U.s. National Institute on Drug Abuse
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Chow, Jonathan J — U.s. National Institute on Drug Abuse
  • Study coordinator: Chow, Jonathan J

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.